Greg Cantin
Amgen (United States)(US)
Publications by Year
Research Areas
Microbial Natural Products and Biosynthesis, Bioactive Compounds and Antitumor Agents, PI3K/AKT/mTOR signaling in cancer, Advanced Proteomics Techniques and Applications, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Transcription Control by E1A and MAP Kinase Pathway via Sur2 Mediator Subunit(2002)237 cited
- → Distinct Protein Classes Including Novel Merozoite Surface Antigens in Raft-like Membranes of Plasmodium falciparum(2005)224 cited
- → Human Proteinpedia enables sharing of human protein data(2008)158 cited
- → Pheromone-Dependent Destruction of the Tec1 Transcription Factor Is Required for MAP Kinase Signaling Specificity in Yeast(2004)157 cited
- → Combining Protein-Based IMAC, Peptide-Based IMAC, and MudPIT for Efficient Phosphoproteomic Analysis(2008)145 cited
- → Optimizing TiO2-Based Phosphopeptide Enrichment for Automated Multidimensional Liquid Chromatography Coupled to Tandem Mass Spectrometry(2007)133 cited
- → CDC25B Mediates Rapamycin-Induced Oncogenic Responses in Cancer Cells(2009)125 cited
- → Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression(2010)118 cited
- → Activation domain–mediator interactions promote transcription preinitiation complex assembly on promoter DNA(2003)106 cited
- → Quantitative Phosphoproteomic Analysis of the Tumor Necrosis Factor Pathway(2005)96 cited